Back to directory

Amyloidosis program

Hospital Universitario Puerta de Hierro Majadahonda

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 3 Rare Subtypes

Contact Information

Primary Contact

Pablo Garcia-Pavia

Head. HF and Inherited Cardiac Diseases Unit

Activity level

  • Patients per year450
  • New diagnoses per year130

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyOn-site
Other specialists
GastroenterologyHepatologyPulmonologyRheumatologyOrthopaedicsGeneticistsGenetic counsellorsNuclear medicine specialistsCardiac imaging specialistsRadiologistsTransplant programme - heartTransplant programme - kidneyTransplant programme - liverPalliative care

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingOn-site
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Apolipoprotein A-I (AApoA1)Apolipoprotein A-IV (AApoAIV)Fibrinogen A alpha-chain (AFib)
Referral pathways

Spanish National Referral Center for Inherited Cardiac Diseases (CSUR)
European Reference center for rare and complex cardiovascular disorders (ERN)

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantAvailable on-site
  • Kidney transplantAvailable on-site
  • Liver transplantAvailable on-site

Patient support services

Services offered
Genetic counsellingNutritional guidance (dietitian)Specialty pharmacyPatient support groupsPalliative care

Networks & telemedicine

  • Telemedicine / virtual consultationNo
  • Part of a formal amyloidosis networkNo
  • Diagnostic services for other organisationsYes
Diagnostic services contact

Last confirmed: 28 March 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.